Shuttle Pharmaceuticals Holdings Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
No analyst estimates are published for this company.
Coverage varies across the market: larger companies are often followed by dozens of analysts, while smaller or recently listed ones may have none.
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Quarterly Report (Form 10-Q) | 16 Nov 2026 |
Monitoring Framework
Key Performance Indicators
Dogecoin Mining Hash Rate Monthly0.0%Target: 43,200 GH/s
Quarterly Net Loss Quarterly-2.2MTarget: Reduce cash burn
Cash and Cash Equivalents Quarterly1.1MTarget: Maintain sufficient working capital
Watch Items
- Deployment of ElphaPex Scrypt Mining RigsTrigger: 60 days post-receipt of equipmentAction: Monitor delivery, site readiness, and initial hash rate generation to verify the 43,200 GH/s target.
- Nasdaq Continued Listing ComplianceTrigger: Minimum bid price falling below $1.00Action: Evaluate the effectiveness of the 1-for-10 reverse stock split executed on June 11, 2026, and monitor stockholders' equity levels relative to the $2.5 million requirement.
- Stockholder Approval for Preferred Stock ConversionTrigger: Proxy vote on Series B-1 Convertible Preferred Stock conversionAction: Track the filing of the proxy statement and subsequent vote to authorize conversion of preferred shares into common stock.
Research as of 20 Jun 2026